R. R. Recker
About
In The Last Decade
R. R. Recker
21 papers receiving 906 citations
Peers
Comparison fields: 5 of 106
- Orthopedics and Sports Medicine 689
- Oncology 467
- Molecular Biology 370
- Surgery 112
- Genetics 104
Countries citing papers authored by R. R. Recker
This map shows the geographic impact of R. R. Recker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. R. Recker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. R. Recker more than expected).
Fields of papers citing papers by R. R. Recker
This network shows the impact of papers produced by R. R. Recker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. R. Recker. The network helps show where R. R. Recker may publish in the future.
Co-authorship network of co-authors of R. R. Recker
This figure shows the co-authorship network connecting the top 25 collaborators of R. R. Recker. A scholar is included among the top collaborators of R. R. Recker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. R. Recker. R. R. Recker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 20 | |
| 3 | High resolution peripheral quantitative CT (HRpQCT) of the radius reflects iliac crest biopsy measures of microstructure and mechanical competence | 0 |
| 4 | 71 | |
| 5 | 98 | |
| 6 | Novel ibandronate regimens in postmenopausal osteoporosis: design of the dosing intravenous administration (DIVA) study | 1 |
| 7 | Bone histology and histomorphometry in a 2-year risedronate study comparing daily and weekly dosing | 2 |
| 8 | American Association of Clinical Endocrinologists 2001 Medical Guidelines for Clinical Practice for the Prevention and Management of Postmenopausal Osteoporosis. | 109 |
| 9 | 6 | |
| 10 | 81 | |
| 11 | Therapeutic equivalence of alendronate 70 mg once-weekly and alendronate 10 mg daily in the treatment of osteoporosis. Alendronate Once-Weekly Study Group. | 235 |
| 12 | 149 | |
| 13 | Current investigative and clinical experience with alendronate in osteoporosis | 0 |
| 14 | 6 | |
| 15 | 2 | |
| 16 | 3 | |
| 17 | 42 | |
| 18 | 5 | |
| 19 | 9 | |
| 20 | Optimum procedure for determining trace aluminum in urine by neutron activation analysis | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.